CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Oksykodonhydroklorid +2 moredrug
Likely dose
Oksykodonhydroklorid 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03023462
NCT03023462N/ACompleted
CompareCT.gov

Efficacy of the Anterior Quadratus Lumborum Block Versus the Transversus Abdominis Plane Block for Elective Laparoscopic Inguinal Hernia Repair: A Randomized Controlled Trial

Ostfold Hospital Trust·interventional·Posted Jan 18, 2017·Updated Nov 18, 2021

In Brief

A clinical study evaluating Oksykodonhydroklorid, Ondansetron and Droperidol, and 1 other intervention for Inguinal Hernia and Pain, Postoperative. Completed, enrolled 60 participants across 1 site.

Detailed Summary

One of the most common complications after hernia repair is postoperative and chronic pain. TAP (transverse abdominis plain) block is a recommended multimodal method of reducing postoperative pain in laparoscopic and open inguinal hernia repair. The objective of this study is to determine whether the use of a perioperative echo guided unilateral TAP block has a superior effect on postoperative pain after laparoscopic inguinal repair compared to an anterior Quadratus Lumborum Block with a long acting local anesthetic.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInguinal Hernia, Pain, Postoperative
CountriesNorway
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 18, 2017
Enrollment StartSep 5, 2019
Primary CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.5 years ago

Interventions

Oksykodonhydrokloriddrug

Oksykodonhydroklorid, 5 - 10 mg intravenously or orally postoperatively to reduce pain. Repetition until effect.

Ondansetron and Droperidoldrug

When nausea and vomiting: Ondansetron 4mg and droperidol 0,625 mg intravenously

Ropivacainedrug

Local anesthetic for the block